{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T21:26:34Z","timestamp":1649193994372},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1986,6,1]],"date-time":"1986-06-01T00:00:00Z","timestamp":517968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1986,6]]},"DOI":"10.1007\/bf00306749","type":"journal-article","created":{"date-parts":[[2004,10,10]],"date-time":"2004-10-10T07:47:58Z","timestamp":1097394478000},"page":"171-176","source":"Crossref","is-referenced-by-count":2,"title":["Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine"],"prefix":"10.1007","volume":"17","author":[{"given":"P.","family":"Bore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Lena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Favre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Carcassonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"2081","volume":"42","author":"C Benz","year":"1982","unstructured":"Benz C (1982) Optimal scheduling of methotrexate and 5-fluorouracil in human breast cancer. Cancer Res 42: 2081?2086","journal-title":"Cancer Res"},{"issue":"Suppl 1","key":"CR2","first-page":"131","volume":"65","author":"JR Bertino","year":"1981","unstructured":"Bertino JR (1981) Clinical use of methotrexate-With emphasis on use of high doses. Cancer Treat Rep 65 [Suppl 1]: 131?135","journal-title":"Cancer Treat Rep"},{"key":"CR3","first-page":"297","volume":"10","author":"JR Bertino","year":"1964","unstructured":"Bertino JR, Fischer GA (1964) Technics for study of resistance to folic acid antagonists. Methods Med Res 10: 297?307","journal-title":"Methods Med Res"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0009-8981(84)90006-8","volume":"141","author":"P Bore","year":"1984","unstructured":"Bore P, Rahmani R, Cano JP et al. (1984) Radioimmunoassays of 7-hydroxymethotrexate and methotrexate. Clin Chim Acta 141: 135?149","journal-title":"Clin Chim Acta"},{"key":"CR5","first-page":"422","volume":"68","author":"P Cappelaere","year":"1981","unstructured":"Cappelaere P, Chauvergne J, Klein T et al. (1981) Randomized trial of vincristine-methotrexate-bleomycin and cis-platin or detorubicin for advanced head and neck cancer. Bull Cancer 68: 422","journal-title":"Bull Cancer"},{"key":"CR6","first-page":"1049","volume":"65","author":"PL Chello","year":"1981","unstructured":"Chello PL, Sirotnak FM (1981) Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia. Cancer Treat Rep 65: 1049?1053","journal-title":"Cancer Treat Rep"},{"key":"CR7","first-page":"2106","volume":"39","author":"PL Chello","year":"1979","unstructured":"Chello PL, Sirotnak FM, Dorick DM (1979) Different effects of vincristine on methotrexate uptake by L1210 cells and mouse intestinal epithelia in vitro and in vivo. Cancer Res 39: 2106?2112","journal-title":"Cancer Res"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1288\/00005537-198107000-00018","volume":"91","author":"TJ Ervin","year":"1981","unstructured":"Ervin TJ, Kirkwood I, Weichselbaum RR et al (1981 a) Improved survival of patients with advanced carcinoma of the head and neck treated by MTX\/LCV prior to definitve XRT or surgery. Laryngoscope, 91: 1181?1190","journal-title":"Laryngoscope"},{"key":"CR9","first-page":"787","volume":"65","author":"TJ Ervin","year":"1981","unstructured":"Ervin TJ, Weichselbaum RR, Miller D, et al. (1981 b) Treatment of advancd squamous cell carcinoma of the head and neck with cis-plantin bleomycin, and methotrexate. Cancer Treat Rep 65: 787?791","journal-title":"Cancer Treat Rep"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1016\/S0021-9258(19)43672-7","volume":"218","author":"MJ Fyfe","year":"1973","unstructured":"Fyfe MJ, Goldmann ID (1973) Characteristics of the vincristine-induced augmentation of methotrexate uptake in Ehrlich ascites tumor cells. J Biol Chem 218: 5067?5073","journal-title":"J Biol Chem"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/1097-0142(19810601)47:11<2552::AID-CNCR2820471106>3.0.CO;2-Y","volume":"47","author":"AM Gewirtz","year":"1981","unstructured":"Gewirtz AM, Cadman E (1981) Preliminary report on the efficacity of sequential methotrexate and 5-fluorouracil in advanced breast cancer. Cancer 47: 2552?2555","journal-title":"Cancer"},{"key":"CR12","volume-title":"Drugs and the pharmaceutical sciences, vol 15","author":"M Gibaldi","year":"1982","unstructured":"Gibaldi M, Perrier D (1982) Pharmacokinetics. In: Swarbrick J (ed) Drugs and the pharmaceutical sciences, vol 15. Dekker, New York"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/1097-0142(19830301)51:5<769::AID-CNCR2820510503>3.0.CO;2-S","volume":"51","author":"GN Hortobagyi","year":"1983","unstructured":"Hortobagyi GN, Yap HY, Blumenschein GR et al (1983) Phase II evaluation of viblastine, methotrexate and calcium leucovorin rescue in patients with refractory metastatic breast cancer. Cancer 51: 769?772","journal-title":"Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/clinchem\/29.6.1317a","volume":"29","author":"AM Imbert","year":"1983","unstructured":"Imbert AM, Pignon T, Lena N (1983) Enzymatic assay for methotrexate with a centrifugal analyzer (Cobas Bio). Clin, Chem 29: 1317","journal-title":"Clin, Chem"},{"key":"CR15","first-page":"1925","volume":"66","author":"C Jacobs","year":"1982","unstructured":"Jacobs C (1982) Use of methotrexate and 5-fluorouracil for recurrent head and neck cancer. Cancer Treat Rep 66: 1925","journal-title":"Cancer Treat Rep"},{"key":"CR16","first-page":"651","volume":"61","author":"SA Jacobs","year":"1977","unstructured":"Jacobs SA, Stoller RG, Chabner BA, Johns DG (1977) Dosedependent metabolism of methotrexate in man and rhesus monkeys. Cancer Treat Rep 61: 651?656","journal-title":"Cancer Treat Rep"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0926-6593(65)80164-3","volume":"105","author":"DJ John","year":"1965","unstructured":"John DJ, Iannotti AT, Sartorelli AC et al (1965) The identity of rabbit liver methotrexate oxidase. Biochim Biophys Acta 105: 380","journal-title":"Biochim Biophys Acta"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jps.2600560310","volume":"56","author":"DG Johns","year":"1967","unstructured":"Johns DG, Loo TL (1967) Metabolite of 4-amino-4-deoxy-N-10-methylpteroyl glutamic acid (methotrexate). J Pharm Sci 56: 356?359","journal-title":"J Pharm Sci"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00254603","volume":"12","author":"N Lena","year":"1984","unstructured":"Lena N, Imbert AM, Pignon T, Faure R Meyer G, Cano JP, Carcassonne Y (1984) Methotrexate-vindesine association in the treatment of head and neck cancer. Influence of vindesine on methotrexate's pharmacokinetic behaviour. Cancer Chemother Pharmacol 12: 120?124","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR20","first-page":"189","volume":"3","author":"S Mojanel","year":"1979","unstructured":"Mojanel S, Rigault J, Cano JP et al (1979) High-dose methotrexate: preliminary evaluation of a pharacokinetic approach. Cancer Chemother Pharmacol 3: 189?196","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/1097-0142(19840215)53:4<841::AID-CNCR2820530404>3.0.CO;2-Z","volume":"53","author":"TE Plasse","year":"1984","unstructured":"Plasse TE, Ohnuma T et al (1984) Bleomycin infusion followed by cyclophosphamide, methotrexate and 5-fluorouracil in advanced squamous carcinoma of the the head and neck. Cancer 53: 841?843","journal-title":"Cancer"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0305-7372(83)80032-2","volume":"10","author":"JK Schornagel","year":"1983","unstructured":"Schornagel JK, McVie JG (1983) The clinical pharmacology of methotrexate. Cancer Treat Rev 10: 53?75","journal-title":"Cancer Treat Rev"},{"key":"CR23","first-page":"19","volume":"6","author":"RG Stoller","year":"1975","unstructured":"Stoller RG, Jacobs SA, Drake JC, et al. (1975) Pharmacokinetics of high-dose methotrexate (NSC-740). Cancer Chemother Rep 6: 19?24","journal-title":"Cancer Chemother Rep"},{"key":"CR24","first-page":"4734","volume":"38","author":"WB Strum","year":"1978","unstructured":"Strum WB, Liem HH, Muller-Eberhead U (1978) Effect of chemotherapeutics agents on the uptake and excretion of amethopterin by the isolated perfused rat liver. Cancer Res 38: 4734?4736","journal-title":"Cancer Res"},{"key":"CR25","first-page":"2993","volume":"37","author":"RD Warren","year":"1977","unstructured":"Warren RD, Nichols AP, Bender RA (1977) The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells. Cancer Res 37: 2993?2997","journal-title":"Cancer Res"},{"key":"CR26","first-page":"1670","volume":"33","author":"RF Zager","year":"1973","unstructured":"Zager RF, Frisby SA, Oliveiro VT (1973) The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia. Cancer Res 33: 1670","journal-title":"Cancer Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00306749.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00306749\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00306749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T10:26:05Z","timestamp":1624703165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00306749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,6]]}},"alternative-id":["BF00306749"],"URL":"https:\/\/doi.org\/10.1007\/bf00306749","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,6]]}}}